Boron-Based Drug Design.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The chemical record

• Publication date

  2015-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/tcr.201402100PMID 25800654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults

  2014cited by this paper
• Diaryl-substituted ortho-carboranes as a new class of hypoxia inducible factor-1α inhibitors.

  2014cited by this paper
• Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.

  2014cited by this paper
• Hsp60 chaperonopathies and chaperonotherapy: targets and agents

  2014cited by this paper
• Identification of malate dehydrogenase 2 as a target protein of the HIF-1 inhibitor LW6 using chemical probes.

  2013cited by this paper
• Development of hypoxia-inducible factor (HIF)-1α inhibitors: effect of ortho-carborane substituents on HIF transcriptional activity under hypoxia.

  2013cited by this paper
• Boron chemicals in diagnosis and therapeutics.

  2013cited by this paper
• Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.

  2013cited by this paper
• Topoisomerase inhibitors as anticancer agents: a patent update

  2013cited by this paper
• Synthesis and Biological Evaluation of Diaryl‐Substituted Carboranes as Inhibitors of Hypoxia Inducible Factor (HIF)‐1 Transcriptional Activity

  2013cited by this paper
• Carborane-based carbonic anhydrase inhibitors.

  2013cited by this paper
• Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy.

  2012cited by this paper
• Chaperonopathies and chaperonotherapy. Hsp60 as therapeutic target in cancer: potential benefits and risks.

  2012cited by this paper
• Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.

  2012cited by this paper
• Boron as a platform for new drug design

  2012cited by this paper
• Design and synthesis of fluorescence-labeled closo-dodecaborate lipid: its liposome formation and in vivo imaging targeting of tumors for boron neutron capture therapy.

  2012cited by this paper
• Boron cluster-based development of potent nonsecosteroidal vitamin D receptor ligands: direct observation of hydrophobic interaction between protein surface and carborane.

  2011cited by this paper
• Carbaboranes as pharmacophores: properties, synthesis, and application strategies.

  2011cited by this paper
• Icosahedral carboranes: Closo-CB11 clusters

  2011cited by this paper
• Discovery of ortho-Carborane-Conjugated Triazines as Selective Topoisomerase I/II Inhibitors

  2011cited by this paper
• Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 – 2010)

  2011cited by this paper
• Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1alpha inhibitors.

  2010cited by this paper
• Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation.

  2010cited by this paper
• Identification of HSP60 as a primary target of o-carboranylphenoxyacetanilide, an HIF-1alpha inhibitor.

  2010cited by this paper
• Discovery of Carboranes as Inducers of 20S Proteasome Activity

  2010cited by this paper
• Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications

  2010cited by this paper
• Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.

  2010cited by this paper
• Selective inhibition of EGFR and VEGFR2 tyrosine kinases controlled by a boronic acid substituent on 4-anilinoquinazolines

  2010cited by this paper
• Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors.

  2009cited by this paper
• Targeting the ubiquitin system in cancer therapy

  2009cited by this paper
• Liposomal boron delivery for neutron capture therapy.

  2009cited by this paper
• Proteasome regulators: activators and inhibitors.

  2009cited by this paper
• Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase.

  2009cited by this paper
• Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma.

  2009cited by this paper
• Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.

  2008cited by this paper
• Structural analysis of spiro beta-lactone proteasome inhibitors.

  2008cited by this paper
• BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

  2008cited by this paper
• A Combinatorial Approach to 2,4,6‐Trisubstituted Triazines with Potent Antimalarial Activity: Combining Conventional Synthesis and Microwave‐Assistance

  2008cited by this paper
• The role of photodynamic therapy (PDT) physics.

  2008cited by this paper
• Synthesis and characterization of polar functional group substituted mono- and bis-(o-carboranyl)-1,3,5-triazine derivatives

  2008cited by this paper
• Boron neutron capture therapy for glioblastoma.

  2008cited by this paper
• The role of photodynamic therapy (PDT) physics.

  2008cited by this paper
• BORON NEUTRON CAPTURE THERAPY FOR MALIGNANT TUMORS RELATED TO MENINGIOMAS

  2007cited by this paper
• Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.

  2007cited by this paper
• An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site

  2007cited by this paper
• (Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors.

  2007cited by this paper
• Synthesis of dodecaborate-conjugated cholesterols for efficient boron delivery in neutron capture therapy

  2007cited by this paper
• Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores

  2007cited by this paper
• Activation and inhibition of the proteasome by betulinic acid and its derivatives

  2007cited by this paper
• Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

  2006cited by this paper
• Recent applications of 2,4,6-trichloro-1,3,5-triazine and its derivatives in organic synthesis

  2006cited by this paper
• Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.

  2006cited by this paper
• The synthesis and use of boronated amino acids for boron neutron capture therapy.

  2006cited by this paper
• Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy.

  2006cited by this paper
• Synthesis and Biological Evaluation of Boronic Acid Containing cis‐Stilbenes as Apoptotic Tubulin Polymerization Inhibitors

  2006cited by this paper
• Lapatinib: A Novel Dual Tyrosine Kinase Inhibitor with Activity in Solid Tumors

  2006cited by this paper
• Erlotinib in previously treated non-small-cell lung cancer.

  2005cited by this paper
• Ion channels: Stopping the flow

  2005cited by this paper
• Saururus cernuus lignans--potent small molecule inhibitors of hypoxia-inducible factor-1.

  2005cited by this paper
• Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib.

  2005cited by this paper
• Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.

  2005cited by this paper
• Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects

  2005cited by this paper
• Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity.

  2005cited by this paper
• Effectiveness of BNCT for recurrent head and neck malignancies.

  2004cited by this paper
• Synthesis and vesicle formation of a nido-carborane cluster lipid for boron neutron capture therapy.

  2004cited by this paper
• Design, Synthesis, and Biological Evaluation of Aminoboronic Acids as Growth‐Factor Receptor Inhibitors of EGFR and VEGFR‐1 Tyrosine Kinases

  2004cited by this paper
• A new structural class of proteasome inhibitors identified by microbial screening using yeast-based assay.

  2004cited by this paper
• Microtubules as a target for anticancer drugs

  2004cited by this paper
• In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: new molecules in anticancer research.

  2004cited by this paper
• Apoptosis induced by topoisomerase inhibitors.

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

  2003cited by this paper
• Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.

  2003cited by this paper
• Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers.

  2003cited by this paper
• o‐Carboranyl derivatives of 1,3,5‐s‐triazines: structures, properties and in vitro activities

  2003cited by this paper
• Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors.

  2002cited by this paper
• Cellular roles of DNA topoisomerases: a molecular perspective

  2002cited by this paper
• Proteasome inhibition: a novel approach to cancer therapy.

  2002cited by this paper
• ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

  2002cited by this paper
• Synthesis and investigation of conformationally restricted analogues of lavendustin A as cytotoxic inhibitors of tubulin polymerization.

  2002cited by this paper
• Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor*

  2002cited by this paper
• Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.

  2001cited by this paper
• Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin.

  2001cited by this paper
• Proteasome inhibitors: from research tools to drug candidates.

  2001cited by this paper
• Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing

  2001cited by this paper
• Mechanisms of Transport of p-Borono-Phenylalanine through the Cell Membrane In Vitro

  2000cited by this paper
• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

  2000cited by this paper
• Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.

  1999cited by this paper
• The Chemistry of Neutron Capture Therapy.

  1998cited by this paper
• Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.

  1998cited by this paper
• Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.

  1997cited by this paper
• Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors

  1997cited by this paper
• Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.

  1992cited by this paper
• Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus.

  1989cited by this paper
• New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial.

  1989cited by this paper
• A revised boron-neutron capture therapy for malignant brain tumors

  1975cited by this paper
• Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds.

  1967cited by this paper
• Synthesis of Aromatic Boronic Acids. Aldehydo Boronic Acids and a Boronic Acid Analog of Tyrosine1

  1958cited by this paper

• Discovery of C-9 boronated berberine derivatives with enhanced selectivity against breast cancer.

  2026cites this paper
• Glioblastoma treatment with Boron Neutron Capture Therapy (BNCT): a revolutionary approach

  2026cites this paper
• Zero-Valent Copper Catalysis Enables Regio- and Stereoselective Difunctionalization of Alkynes.

  2025cites this paper
• Synthesis and structure characterization of boron complexes containing C2-symmetric tertiary amine ligands: Assessment catalytic degradation of dyes and antioxidant properties

  2025cites this paper
• Direct Conversion of Aromatic Lactones into Bioisosteres by Carbonyl-to-Boranol Exchange.

  2025cites this paper
• Dehomologative C–C Borylation of Aldehydes and Alcohols via a Rh-Catalyzed Dehydroformylation–Borylation Relay

  2025cites this paper
• Recent Development of Boron-Containing Small-Molecule Anticancer Agents.

  2025cites this paper
• A Comprehensive Review of the Pharmacological, Therapeutic, and Toxicological Properties of Boric Acid and Other Boron-Containing Compounds: Current Landscape and Future Perspectives

  2025cites this paper
• Targeting Osteosarcoma: The Dual Action of Halogenated Boroxine and Cerium Oxide Nanoparticles

  2025cites this paper
• Ni-catalyzed enantioselective synthesis of β-aminoboronates via spin-center shift and proton transfer

  2025cites this paper
• Recent Advancements in the Diversification and Applications of Boron-Containing Compounds in Medicinal Chemistry

  2025cites this paper
• Inhibition of Mandelate Racemase by Boron-Based Inhibitors: Different Binding Modes for Benzoxaboroles Versus Boronic Acids.

  2025cites this paper
• Isolated Neutral Organic Radical Unveiled Solvent-Radical Interaction in Highly Reducing Photocatalysis.

  2025cites this paper
• Azobenzene-Tagged Photopeptides Exhibiting Excellent Selectivity and Light-Induced Cytotoxicity in MCF-7 Cells over HeLa and A549.

  2024cites this paper
• Luminescent o-Carboranyl-Containing Molecules: A Promising Platform for Stimuli-Responsive Smart Materials

  2024cites this paper
• Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: Ex Novo Synthesis, Crystallography, In Silico Studies, and Anti-Melanoma Cell Line Activity.

  2024cites this paper
• Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales.

  2024cites this paper
• Size‐Dependent Photocatalytic Reactivity of Conjugated Microporous Polymer Nanoparticles

  2024cites this paper
• One-Step Synthesis, Crystallography, and Acute Toxicity of Two Boron–Carbohydrate Adducts That Induce Sedation in Mice

  2024cites this paper
• Synthesis of Carboranylated Dihydropyrrolo[1,2-a]quinoxalines and Dihydroindolo[1,2-a]quinoxalines by BF3·OEt2-Catalyzed Heterocyclization of C-Formyl-o-carboranes and Investigation of Their Oxidation Stability.

  2024cites this paper
• Facile Synthesis of Vinyl Boronate Esters via Dehydrogenative Borylation of Alkenes Enabled by a Co-MOF Catalyst: An Additive-Free Approach

  2024cites this paper
• Tetrahedral Boronate Ester as Regulators of Inflammation and Adhesion in ox-LDL Induced Atherosclerotic Model

  2024cites this paper
• Fluorescence In Situ Hybridization-Based Chromosome Aberration Analysis Unveils the Mechanistic Basis for Boron-Neutron Capture Therapy’s Radiobiological Effectiveness

  2024cites this paper
• Molecular engineering of AIE-active boron clustoluminogens for enhanced boron neutron capture therapy

  2024cites this paper
• Molecular insights into the dynamic modulation of bacterial ClpP function and oligomerization by peptidomimetic boronate compounds

  2024cites this paper
• 11B NMR of the Morphological Evolution of Traditional Chinese Medicine Borax

  2024cites this paper
• Arylazo sulfones: multifaceted photochemical reagents and beyond.

  2024cites this paper
• Sustainable Synthesis of Substituted 1,3,5-Triazines by [ONO]-Pincer-Supported Nickel(II) Complexes via an Acceptorless Dehydrogenative Coupling Strategy.

  2024cites this paper
• Capturing the free energy of transition state stabilization: insights from the inhibition of mandelate racemase

  2023cites this paper
• Nanostructured boron agents for boron neutron capture therapy: a review of recent patents

  2023cites this paper
• Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design.

  2023cites this paper
• Facile synthesis of arylboronates via recyclable copper(I)-catalyzed cross-coupling of pinacolborane with aryl iodides under mild conditions

  2023cites this paper
• 6-Substituted Triazolyl Benzoxaboroles as Selective Carbonic Anhydrase Inhibitors: In Silico Design, Synthesis, and X-ray Crystallography.

  2023cites this paper
• Recent research of BTK inhibitors: Methods of structural design, pharmacological activities, manmade derivatives and structure-activity relationship.

  2023cites this paper
• Boron-containing carbonic anhydrases inhibitors.

  2023cites this paper
• Mechanism and Origins of Regio- and Stereoselective Alkylboration of Endocyclic Olefins Enabled by Nickel Catalysis.

  2023cites this paper
• Cope-Type Hydroamination of Vinylboronates.

  2023cites this paper
• Mechanistic study of homoleptic trisamidolanthanide-catalyzed aldehyde and ketone hydroboration. Chemically non-innocent ligand participation

  2023cites this paper
• Catalytic asymmetric synthesis of carboranylated diols bearing two adjacent stereocenters located at the α,β-position of o-carborane cage carbon.

  2023cites this paper
• Aryl Boronic Acids in Columnar Stacked Co-crystalline Materials: Key-Factors Governing the Assembly with Quinones.

  2023cites this paper
• Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT)

  2022cites this paper
• The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry

  2022cites this paper
• Isolated Neutral [4]Helicene Radical Provides Insight into Consecutive Two-Photon Excitation Photocatalysis

  2022cites this paper
• Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect

  2022cites this paper
• Animal Tumor Models for Boron Neutron Capture Therapy Studies (Excluding Central Nervous System Solid Tumors).

  2022cites this paper
• Carboranes in drug discovery, chemical biology and molecular imaging

  2022cites this paper
• Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases.

  2022cites this paper
• Palladium-Catalyzed Hydroboration of Alkynes with Carboranes: Facile Construction of a Library of Boron Cluster-Based AIE-Active Luminogens.

  2022cites this paper
• Transfer C–H borylation of alkenes under Rh(I) catalysis: Insight into the synthetic capacity, mechanism, and selectivity control

  2022cites this paper
• Rhodium-catalysed selective C–C bond activation and borylation of cyclopropanes

  2021cites this paper
• Red light-emitting Carborane-BODIPY dyes: Synthesis and properties of visible-light tuned fluorophores with enhanced boron content

  2021cites this paper
• Computational study on the mechanism of metal-free photochemical borylation of aryl halides

  2021cites this paper
• α-Aminoboronates: recent advances in their preparation and synthetic applications.

  2021cites this paper
• First-Row d-Block Element-Catalyzed Carbon-Boron Bond Formation and Related Processes.

  2021cites this paper
• Exploring Covalent Docking Mechanisms of Boron-Based Inhibitors to Class A, C and D β-Lactamases Using Time-dependent Hybrid QM/MM Simulations

  2021cites this paper
• Strike a Balance: Between Metals and Non-Metals, Metalloids as a Source of Anti-Infective Agents

  2021cites this paper
• Merging the Versatile Functionalities of Boronic Acid with Peptides

  2021cites this paper
• Boronic-Acid-Modified Nanomaterials for Biomedical Applications

  2021cites this paper
• Ru(II) and Ir(III) phenanthroline-based photosensitisers bearing o-carborane: PDT agents with boron carriers for potential BNCT.

  2021cites this paper
• Recent advances in the selective functionalization of anionic icosahedral boranes and carboranes

  2021cites this paper
• Boronic Acid Pairs for Sequential Bioconjugation.

  2021cites this paper
• Recent progress in self-healing polymers and hydrogels based on reversible dynamic B–O bonds: boronic/boronate esters, borax, and benzoxaborole

  2021cites this paper
• Electrochemical Thiolation and Borylation of Arylazo Sulfones with Thiols and B 2 pin 2

  2021cites this paper
• Quantification of boron in cells for evaluation of drug agents used in boron neutron capture therapy

  2021cites this paper
• Catalyst-Free Organic Transformations under Visible-Light

  2021cites this paper
• Recent developments in the synthesis of bioactive boron-containing compounds

  2021cites this paper
• Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases.

  2020cites this paper
• Utility of boron in dermatology

  2020cites this paper
• Visible Light-Induced Borylation of C-O, C-N, and C-X Bonds.

  2020cites this paper
• Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer.

  2020cites this paper
• Isonitrile-Based Multicomponent Synthesis of β-Amino Boronic Acids as β-Lactamase Inhibitors

  2020cites this paper
• The synthesis of novel boronate esters and N-Heterocyclic carbene (NHC)-stabilized boronate esters: Spectroscopy, antimicrobial and antioxidant studies

  2020cites this paper
• Synthesis and electrochemical investigation of chiral amine bis(phenolate)-boron complexes: In vitro antibacterial activity screening of boron compounds

  2020cites this paper
• Synthesis of cis ‐1,2‐diol‐type chiral ligands and their dioxaborinane derivatives: Application for the asymmetric transfer hydrogenation of various ketones and biological evaluation

  2020cites this paper
• Tuning the cell uptake and subcellular distribution in BODIPY-carboranyl dyads: An experimental and theoretical study.

  2020cites this paper
• Potent Inhibition of Mandelate Racemase by Boronic Acids: Boron as a Mimic of a Carbon Acid Center.

  2020cites this paper
• Synthesis and Applications of β‐Aminoalkylboronic Acid Derivatives

  2020cites this paper
• Hydroboration of Enynes and Mechanistic Insights

  2020cites this paper
• Inhibition of histone deacetylases, topoisomerases and epidermal growth factor receptor by metal-based anticancer agents: Design & synthetic strategies and their medicinal attributes.

  2020cites this paper
• In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells

  2020cites this paper
• Electron transfer to phenyl boronic acid upon potassium collisions

  2020cites this paper
• Synthesis of boronophenylalanine-like aza-amino acids for boron-containing azapeptide precursors

  2020cites this paper
• Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors.

  2019cites this paper
• The Borono-Strecker Reaction: Synthesis of α-Aminoboronates via a Multicomponent Reaction of Carbonyl Compounds, Amines, and B2pin2.

  2019cites this paper
• Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response

  2019cites this paper
• The Role of Electron Transfer in the Fragmentation of Phenyl and Cyclohexyl Boronic Acids

  2019cites this paper
• Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents.

  2019cites this paper
• Highly selective palladium-catalyzed one-pot, five-fold B–H/C–H cross coupling of monocarboranes with alkenes

  2019cites this paper
• Chemical bonding and nonadiabatic electron wavepacket dynamics in densely quasi-degenerate excited electronic state manifold of boron clusters.

  2019cites this paper
• Design, synthesis and preliminary in-vitro studies of novel boronated monocarbonyl analogues of Curcumin (BMAC) for antitumor and β-amiloyd disaggregation activity.

  2019cites this paper
• Design, synthesis and evaluations of spiro‐fused benzoxaborin derivatives as novel boron‐containing compounds

  2019cites this paper
• Aggregation-Induced Electrochemiluminescence of Carboranyl Carbazoles in Aqueous Media.

  2019cites this paper
• Theoretical Coupling and Stability of Boronic Acid Adducts with Catecholamines

  2019cites this paper
• New avenues for C–B bond formation via radical intermediates

  2019cites this paper
• Bis-benzoxaboroles: Design, Synthesis, and Biological Evaluation as Carbonic Anhydrase Inhibitors.

  2019cites this paper
• Boron in drug design: Recent advances in the development of new therapeutic agents.

  2019cites this paper
• Twenty Years of Research on 3-Carboranyl Thymidine Analogs (3CTAs)

  2018cites this paper
• Modular Synthesis of β-Amino Boronate Peptidomimetics.

  2018cites this paper
• Trace Elements in Human Health

  2018cites this paper
• Quantum Monte Carlo study of the electron binding energies and aromaticity of small neutral and charged boron clusters.

  2018cites this paper